Organization · Private Equity
Xerys
Xerys is a private equity firm based in Paris, France, specializing in investments in health and sustainable development sectors. The firm supports small and medium-sized enterprises throughout their growth stages.
Overview
What Xerys does
What Xerys is
Xerys is a private equity firm based in Paris, France, specializing in investments in health and sustainable development sectors. The firm supports small and medium-sized enterprises throughout their growth stages.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Private Equity
- Founded
- Founded in 2014
- Approximate age
- About 12 years
- Structured capabilities
- Funder
- Last reviewed
- March 4, 2026
Official channels
Find Xerys elsewhere
Open the official website or a supported primary organization account.
Capability profile
Xerys as a funder
Investment thesis
Xerys invests in small and medium-sized enterprises (SMEs) in France, focusing on health and sustainable development sectors. The organization aims for long-term growth with an investment horizon of 6 to 8 years.
Focus narrative
Xerys invests primarily in two sectors: health (including medtech and biotech) and sustainable development (including greentech, cleantech, and climate tech). The company targets small and medium-sized enterprises (SMEs) in France, with investment tickets ranging from €15 million to €90 million. The investment horizon is typically 6 to 8 years, with potential exits through industrial sales, other investment funds, or public offerings.
Terms and economics
- Typical check
- $15,000,000–$90,000,000
Focus and fit
- Stages
- Friends and Family · Angel · Seed · Seed+ · Series A · Series B · Series C · Growth Equity
Availability
- Currently deploying
- Not published
Portfolio and track record
Portfolio context
Notable portfolio companies include: Advanced BioDesign: A French biotechnology company developing targeted therapies for resistant cancers. AlzProtect: Focuses on developing medications for neurodegenerative diseases, including Alzheimer's disease. Biolog-id: Develops solutions for identification and traceability in healthcare to improve workflows and patient safety. Powidian: A spin-off from Airbus, specializing in long-duration energy storage systems and decentralized electricity production. Skytech: Innovates in sorting industrial plastics from recycling to produce regenerated plastic materials. Optionizr: A fintech company offering alternative payment methods, primarily in the leisure tourism sector.
Common questions
What to know about Xerys
Upseed classifies Xerys under the Private Equity organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 4, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.